AUPH peer analysis
Aurinia Pharmaceuticals (AUPH) against its competitors: price, today's move, 1-year return and market value side by side.
- AUPH's peers: ACRS (Aclaris Therapeutics), ALMS (Alumis), ATTO (Attovia Therapeutics), BHVN (Biohaven), ELDN (Eledon Pharmaceuticals), EVMN (Evommune), MLTX (MoonLake Immunotherapeutics), TRAX (First Tracks Biotherapeutics).
AUPH and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.44 | -1.71% | 39.84% | $545.63M |
| ALMS Alumis | $4.03 | -6.93% | -38.66% | $523.18M |
| ATTO Attovia Therapeutics | $15.10 | -3.08% | – | $690.26M |
| BHVN Biohaven | $12.51 | -8.35% | 32.24% | $1.89B |
| ELDN Eledon Pharmaceuticals | $1.80 | -5.28% | 16.10% | $151.99M |
| EVMN Evommune | $7.03 | -2.90% | -63.56% | $290.69M |
| MLTX MoonLake Immunotherapeutics | $11.07 | 0.36% | -18.24% | $942.13M |
| TRAX First Tracks Biotherapeutics | $40.70 | -8.46% | – | $1.71B |
| VERA Vera Therapeutics | $24.88 | -6.99% | -12.86% | $1.80B |
| AUPH Aurinia Pharmaceuticals | $14.64 | -1.69% | -3.69% | $1.96B |